A new Phase Ib/II study from researchers at The University of Texas MD Anderson Cancer Center and Moffitt Cancer Center found that combining sensitizing drugs with a specific form of radiation therapy may be more effective in patients with locally advanced pancreatic cancer, yielding a higher progression-free survival (PFS) and overall response rate (ORR).
Opinion | Why Medicine Is Bad at Customer Service — And How to Fix It
Theisen is a nurse and healthcare executive. American business is delivering one of history’s greatest revolutions in customer convenience — except in our industry, the
October 30, 2024